subscribeSubscribe
Medsenic amends licence agreement with Phebra for arsenic trioxide

Medsenic amends licence agreement with Phebra for arsenic trioxide
PHARMACEUTICAL TECHNOLOGY
30 May 2023
Share Share
BioSenic SA provides update on its autoimmune disease platform based on ATO

BioSenic SA provides update on its autoimmune disease platform based on ATO
GLOBENEWSWIRE
07 Nov 2022
Share Share
Medsenic Publishes an Article in Transplantation and Cellular Therapy

Medsenic Publishes an Article in Transplantation and Cellular Therapy
BUSINESSWIRE
18 Jul 2022
Share Share
Drug combination an alternative leukaemia treatment to chemotherapy

Drug combination an alternative leukaemia treatment to chemotherapy
Anna Begley EUROPEANPHARMACEUTICALREVIEW
12 Nov 2021
Share Share
Eugia Pharma’s Generics Arsenic Trioxide Receives Approvals In US

Eugia Pharma’s Generics Arsenic Trioxide Receives Approvals In US
FDA
19 Oct 2021
Share Share
USPTO Grants Patent to Medsenic`s Arsenic Trioxide in Multiple Sclerosis

USPTO Grants Patent to Medsenic`s Arsenic Trioxide in Multiple Sclerosis
BUSINESSWIRE
29 Sep 2021
Share Share
Syros Initiates Dosing in SY-2101, Oral Form of Arsenic Trioxide, in Leukemia

Syros Initiates Dosing in SY-2101, Oral Form of Arsenic Trioxide, in Leukemia
BUSINESSWIRE
29 Sep 2021
Share Share
medac Gesellschaft für Arsenic trioxide medac Receives Approval in Europe

medac Gesellschaft für Arsenic trioxide medac Receives Approval in Europe
EMA
01 Oct 2020
Share Share
Medac GmbH`s Arsenictrioxide medac (ArsenicTrioxide) Receives Approval In Europe

Medac GmbH`s Arsenictrioxide medac (ArsenicTrioxide) Receives Approval In Europe
EMA
01 Oct 2020
Share Share
EMA: Thumbs up for 11, down for 2 new medicines

EMA: Thumbs up for 11, down for 2 new medicines
Kari Oakes RAPS
25 Jul 2020
Share Share